Trials / Active Not Recruiting
Active Not RecruitingNCT07145502
Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 76 (actual)
- Sponsor
- Biocells Medical · Industry
- Sex
- All
- Age
- 6 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, non-randomized, observational registry study evaluating the clinical outcomes of patients with autoimmune or post-infectious neuroinflammatory syndromes receiving stem cell-derived biologics (including mesenchymal stem cells and exosomes) at Biocells Medical clinics. The study aims to track improvements in neurological function, inflammatory biomarkers, and patient-reported quality of life following individualized regenerative interventions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Allogeneic MSC infusions (IV) | Optional T-reg therapy (experimental/compassionate-use basis) |
Timeline
- Start date
- 2022-09-19
- Primary completion
- 2024-07-15
- Completion
- 2027-09-19
- First posted
- 2025-08-28
- Last updated
- 2025-09-05
Locations
1 site across 1 country: Poland
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07145502. Inclusion in this directory is not an endorsement.